Hemant Phatak

Relationships Between Beliefs about Medications and Nonadherence to Prescribed Chronic Medications

Hemant Phatak, Joseph Thomas · Annals of Pharmacotherapy · 2006 · 181 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +14

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States

Gregory Y.H. Lip, Xianying Pan, Shital Kamble et al. · International Journal of Clinical Practice · 2016 · 105 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation

Paul Dorian, Thitima Kongnakorn, Hemant Phatak et al. · European Heart Journal · 2014 · 99 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16

Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Gregory Y.H. Lip, Thitima Kongnakorn, Hemant Phatak et al. · Clinical Therapeutics · 2014 · 87 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups

Gregory Y.H. Lip, Stephen Mitchell, Xianchen Liu et al. · International Journal of Cardiology · 2015 · 87 citations

Medicine, Cardiology, Pharmacotherapy +10